why choose us

First received: April 29, 2024

Clinical Trial: A Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Basic Science

Study Type: INTERVENTIONAL


Official Title: A Randomized, Placebo- and Positive-controlled, Crossover Study to Assess the Effect of Olpasiran (AMG 890) on QT/QTc Intervals in Healthy Subjects

Brief Summary: The primary objective of the study is:• To assess the effects of a single therapeutic and supratherapeutic dose of olpasiran on the placebo-corrected change from baseline in QT corrected for heart rate (??QT)/QTc interval in healthy participants.

Read more